$9.080
-0.252 (-2.78%)終値時点
MSLE の同業比較
In the context of the broader market, MSLE competes directly with industry leaders such as ELDN and NMRA. With a market capitalization of $198.16M, it holds a significant position in the sector. When comparing efficiency, MSLE's gross margin of N/A stands against ELDN's N/A and NMRA's N/A. Such benchmarking helps identify whether Satellos Bioscience Inc. is trading at a premium or discount relative to its financial performance.
Satellos Bioscience Inc の財務パフォーマンス
Satellos has been experiencing significant net losses, with the latest reported net income of -11,718,000 USD for Q2 2026. The company has a current ratio of 11.22, indicating strong liquidity, but the overall financial health is challenged by ongoing losses.
Financials
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。